These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 36289914)

  • 1. Investigation of the Effect of Exendin-4 on Oleic Acid-Induced Steatosis in HepG2 Cells Using Fourier Transform Infrared Spectroscopy.
    Khalifa O; H Mroue K; Mall R; Ullah E; S Al-Akl N; Arredouani A
    Biomedicines; 2022 Oct; 10(10):. PubMed ID: 36289914
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comprehensive analysis of LncRNAs expression profiles in an in vitro model of steatosis treated with Exendin-4.
    Errafii K; Al-Akl NS; Khalifa O; Arredouani A
    J Transl Med; 2021 Jun; 19(1):235. PubMed ID: 34078383
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative Transcriptome Analysis Reveals That Exendin-4 Improves Steatosis in HepG2 Cells by Modulating Signaling Pathways Related to Lipid Metabolism.
    Errafii K; Khalifa O; Al-Akl NS; Arredouani A
    Biomedicines; 2022 Apr; 10(5):. PubMed ID: 35625757
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exendin-4 alleviates steatosis in an in vitro cell model by lowering FABP1 and FOXA1 expression via the Wnt/-catenin signaling pathway.
    Khalifa O; Al-Akl NS; Errafii K; Arredouani A
    Sci Rep; 2022 Feb; 12(1):2226. PubMed ID: 35140289
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low simvastatin concentrations reduce oleic acid-induced steatosis in HepG
    Alkhatatbeh MJ; Lincz LF; Thorne RF
    Exp Ther Med; 2016 Apr; 11(4):1487-1492. PubMed ID: 27073470
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liraglutide Alleviates Hepatic Steatosis by Activating the TFEB-Regulated Autophagy-Lysosomal Pathway.
    Fang Y; Ji L; Zhu C; Xiao Y; Zhang J; Lu J; Yin J; Wei L
    Front Cell Dev Biol; 2020; 8():602574. PubMed ID: 33330497
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exendin-4, a glucagon-like peptide-1 receptor agonist, reduces hepatic steatosis and endoplasmic reticulum stress by inducing nuclear factor erythroid-derived 2-related factor 2 nuclear translocation.
    Yoo J; Cho IJ; Jeong IK; Ahn KJ; Chung HY; Hwang YC
    Toxicol Appl Pharmacol; 2018 Dec; 360():18-29. PubMed ID: 30253173
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amelioration by chicory seed extract of diabetes- and oleic acid-induced non-alcoholic fatty liver disease (NAFLD)/non-alcoholic steatohepatitis (NASH) via modulation of PPARα and SREBP-1.
    Ziamajidi N; Khaghani S; Hassanzadeh G; Vardasbi S; Ahmadian S; Nowrouzi A; Ghaffari SM; Abdirad A
    Food Chem Toxicol; 2013 Aug; 58():198-209. PubMed ID: 23603006
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lycopus lucidus Turcz. ex Benth. Attenuates free fatty acid-induced steatosis in HepG2 cells and non-alcoholic fatty liver disease in high-fat diet-induced obese mice.
    Lee MR; Yang HJ; Park KI; Ma JY
    Phytomedicine; 2019 Mar; 55():14-22. PubMed ID: 30668424
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PPAR agonists reduce steatosis in oleic acid-overloaded HepaRG cells.
    Rogue A; Anthérieu S; Vluggens A; Umbdenstock T; Claude N; de la Moureyre-Spire C; Weaver RJ; Guillouzo A
    Toxicol Appl Pharmacol; 2014 Apr; 276(1):73-81. PubMed ID: 24534255
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemical imaging on liver steatosis using synchrotron infrared and ToF-SIMS microspectroscopies.
    Le Naour F; Bralet MP; Debois D; Sandt C; Guettier C; Dumas P; Brunelle A; Laprévote O
    PLoS One; 2009 Oct; 4(10):e7408. PubMed ID: 19823674
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The beneficial effects of resveratrol on steatosis and mitochondrial oxidative stress in HepG2 cells.
    Izdebska M; Piątkowska-Chmiel I; Korolczuk A; Herbet M; Gawrońska-Grzywacz M; Gieroba R; Sysa M; Czajkowska-Bania K; Cygal M; Korga A; Dudka J
    Can J Physiol Pharmacol; 2017 Dec; 95(12):1442-1453. PubMed ID: 28759727
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The glucagon-like peptide-1 analogue exendin-4 reverses impaired intracellular Ca(2+) signalling in steatotic hepatocytes.
    Ali ES; Hua J; Wilson CH; Tallis GA; Zhou FH; Rychkov GY; Barritt GJ
    Biochim Biophys Acta; 2016 Sep; 1863(9):2135-46. PubMed ID: 27178543
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of exendin-4-induced steatosis by protein kinase A in cultured HepG2 human hepatoma cells.
    Chen-Liaw AY; Hammel G; Gomez G
    In Vitro Cell Dev Biol Anim; 2017 Sep; 53(8):721-727. PubMed ID: 28707223
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vibrational signatures to discriminate liver steatosis grades.
    Peng C; Chiappini F; Kaščáková S; Danulot M; Sandt C; Samuel D; Dumas P; Guettier C; Le Naour F
    Analyst; 2015 Feb; 140(4):1107-18. PubMed ID: 25581590
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dulaglutide Ameliorates Palmitic Acid-Induced Hepatic Steatosis by Activating FAM3A Signaling Pathway.
    Lee J; Hong SW; Kim MJ; Moon SJ; Kwon H; Park SE; Rhee EJ; Lee WY
    Endocrinol Metab (Seoul); 2022 Feb; 37(1):74-83. PubMed ID: 35144334
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Exendin-4 promotes autophagy to relieve lipid deposition in a NAFLD cell model by activating AKT/mTOR signaling pathway].
    Lin C; Fang J; Xiang Q; Zhou R; Yang L
    Nan Fang Yi Ke Da Xue Xue Bao; 2021 Jul; 41(7):1073-1078. PubMed ID: 34308859
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liraglutide reduces lipid accumulation in steatotic L‑02 cells by enhancing autophagy.
    Zhou SW; Zhang M; Zhu M
    Mol Med Rep; 2014 Nov; 10(5):2351-7. PubMed ID: 25230688
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kangtaizhi Granule Alleviated Nonalcoholic Fatty Liver Disease in High-Fat Diet-Fed Rats and HepG2 Cells via AMPK/mTOR Signaling Pathway.
    Zhang J; Du H; Shen M; Zhao Z; Ye X
    J Immunol Res; 2020; 2020():3413186. PubMed ID: 32884949
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dihydromyricetin ameliorates oleic acid-induced lipid accumulation in L02 and HepG2 cells by inhibiting lipogenesis and oxidative stress.
    Xie C; Chen Z; Zhang C; Xu X; Jin J; Zhan W; Han T; Wang J
    Life Sci; 2016 Jul; 157():131-139. PubMed ID: 27265384
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.